Long-Acting Injectable Antipsychotics in the Era of COVID-19

November 19, 2020
Frank Chen, MD

COVID-19 has made treating patients who receive long-acting injectables complicated. The Chief Medical Officer of Houston Behavioral Healthcare Hospital offers suggestions on how best to proceed.

The training wheels on telepsychiatry have been yanked off. Where it was once an exception, telepsychiatry is the new norm. But how does this impact the patients who need more intense care?

Frank Chen, MD, explains.

Dr Chen is Chief Medical Officer at Houston Behavioral Healthcare Hospital.